<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02086500</url>
  </required_header>
  <id_info>
    <org_study_id>W81XWH1320080 IND 121102</org_study_id>
    <nct_id>NCT02086500</nct_id>
  </id_info>
  <brief_title>Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)</brief_title>
  <acronym>STAAMP</acronym>
  <official_title>Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial For Trauma Patients At Risk Of Hemorrhage (STAAMP Trial); Phase III Multicenter, Prospective, Randomized, Double Blind, Interventional Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jason Sperry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas at San Antonio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if 1 gram of prehospital tranexamic acid given&#xD;
      during emergency medical transport to a level 1 trauma center in patients at risk of&#xD;
      hemorrhage is associated with lower 30 day mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Traumatically injured patients continue to be plagued with uncontrolled&#xD;
      hemorrhage resulting in significant morbidity and early mortality. A primary driving force&#xD;
      for this unbridled hemorrhage is known to be the early coagulopathy which complicates severe&#xD;
      injury. Trauma induced coagulopathy has been postulated to be an equilibrium imbalance&#xD;
      between pro and anticoagulant factors, platelets, endothelium and fibrinolysis soon after&#xD;
      injury. Recent evidence demonstrates that the early use of the antifibrinolytic agent&#xD;
      tranexamic acid (TXA) after trauma center arrival results in improved survival in patients at&#xD;
      risk for bleeding. Bringing this proven treatment to the prehospital arena and intervening&#xD;
      earlier in those patients who would otherwise not be candidates for treatment has the real&#xD;
      potential to further reduce or prevent the vicious hemorrhagic cascade, improve clinical&#xD;
      outcomes and provide insight into the underlying mechanisms responsible for and which&#xD;
      maximize its benefit.&#xD;
&#xD;
      Objective/Hypothesis: The primary hypothesis will be that prehospital infusion of tranexamic&#xD;
      acid in patients at risk for bleeding will reduce the incidence of 30 day mortality. The&#xD;
      secondary hypotheses include that prehospital tranexamic acid will reduce the incidence of&#xD;
      hyperfibrinolysis, acute lung injury, multiple organ failure, nosocomial infection,&#xD;
      mortality, early seizures, pulmonary embolism and early resuscitation needs, reduce or&#xD;
      prevent the early coagulopathy as demonstrated by improving presenting INR and rapid&#xD;
      thromboelastography parameters, reduce the early inflammatory response, plasmin levels,&#xD;
      leukocyte, platelet and complement activation, and determine the optimal dosing of tranexamic&#xD;
      acid post-injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">November 2019</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30 Day Mortality</measure>
    <time_frame>30 Day</time_frame>
    <description>Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>24 Hour Mortality</measure>
    <time_frame>24 Hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Lung Injury</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple Organ Failure</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nosocomial Infection</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 Hour Total Blood Transfusion</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperfinbrinolysis</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">903</enrollment>
  <condition>Traumatic Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Prehospital Tranexamic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 gram of Tranexamic Acid will be given during emergency medical transport</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Identical volume of saline during emergency medical transport</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>1 gram of prehospital Tranexamic Acid</description>
    <arm_group_label>Prehospital Tranexamic Acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline control</intervention_name>
    <description>Saline Control</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Blunt or penetrating injured patients at risk of bleeding being transported via air or&#xD;
             ground medical services from the scene of injury or from referring hospital to a&#xD;
             definitive trauma center that is participating in the trial AND&#xD;
&#xD;
          2. Within 2 hours of time of injury AND&#xD;
&#xD;
          3. Hypotension (Systolic Blood Pressure (SBP) &lt; 90mmHg)&#xD;
&#xD;
               -  At scene of injury or during air or ground medical transport&#xD;
&#xD;
               -  Documented at referring hospital prior to air or ground medical transport arrival&#xD;
&#xD;
             OR&#xD;
&#xD;
          4. Tachycardia (heart rate &gt;110 beats per minute)&#xD;
&#xD;
               -  At scene of injury or during air or ground medical transport&#xD;
&#xD;
               -  Documented at referring hospital prior to air or ground medical transport arrival&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age &gt; 90 or &lt; 18 years of age&#xD;
&#xD;
          2. Inability to obtain intravenous access or intraosseous&#xD;
&#xD;
          3. Documented (radiographic evidence) cervical cord injury with motor deficit&#xD;
&#xD;
          4. Known prisoner&#xD;
&#xD;
          5. Known pregnancy&#xD;
&#xD;
          6. Traumatic arrest with &gt; 5 minutes CPR without return of vital signs&#xD;
&#xD;
          7. Penetrating cranial injury&#xD;
&#xD;
          8. Traumatic brain injury with brain matter exposed&#xD;
&#xD;
          9. Isolated drowning or hanging victims&#xD;
&#xD;
         10. Wearing an opt out bracelet.&#xD;
&#xD;
         11. Isolated fall from standing&#xD;
&#xD;
         12. Patient or Family Objection at scene&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 6, 2014</study_first_submitted>
  <study_first_submitted_qc>March 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <results_first_submitted>July 11, 2020</results_first_submitted>
  <results_first_submitted_qc>September 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 10, 2020</results_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Jason Sperry</investigator_full_name>
    <investigator_title>MD, MPH</investigator_title>
  </responsible_party>
  <keyword>Tranexamic acid</keyword>
  <keyword>randomized</keyword>
  <keyword>hemorrhage</keyword>
  <keyword>blinded</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/00/NCT02086500/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Prehospital Tranexamic Acid</title>
          <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="447"/>
                <participants group_id="P2" count="456"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="447"/>
                <participants group_id="P2" count="456"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>of the 927 patients enrolled in the prehospital environment, 903 were able to be analyzed</population>
      <group_list>
        <group group_id="B1">
          <title>Prehospital Tranexamic Acid</title>
          <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="447"/>
            <count group_id="B2" value="456"/>
            <count group_id="B3" value="903"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39" lower_limit="26" upper_limit="53"/>
                    <measurement group_id="B2" value="39" lower_limit="26" upper_limit="56"/>
                    <measurement group_id="B3" value="39" lower_limit="26" upper_limit="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="235"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="327"/>
                    <measurement group_id="B2" value="341"/>
                    <measurement group_id="B3" value="668"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="353"/>
                    <measurement group_id="B2" value="361"/>
                    <measurement group_id="B3" value="714"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>30 Day Mortality</title>
        <description>Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.</description>
        <time_frame>30 Day</time_frame>
        <population>Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.</population>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>30 Day Mortality</title>
          <description>Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.</description>
          <population>Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="452"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24 Hour Mortality</title>
        <time_frame>24 Hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>24 Hour Mortality</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acute Lung Injury</title>
        <time_frame>7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Lung Injury</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Multiple Organ Failure</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>Multiple Organ Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nosocomial Infection</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>Nosocomial Infection</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24 Hour Total Blood Transfusion</title>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>24 Hour Total Blood Transfusion</title>
          <units>units of blood transfusion</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hyperfinbrinolysis</title>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prehospital Tranexamic Acid</title>
            <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
          </group>
        </group_list>
        <measure>
          <title>Hyperfinbrinolysis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="447"/>
                <count group_id="O2" value="453"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145"/>
                    <measurement group_id="O2" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Hospital Admission to 30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Prehospital Tranexamic Acid</title>
          <description>1 gram of Tranexamic Acid will be given during emergency medical transport&#xD;
Tranexamic Acid: 1 gram of prehospital Tranexamic Acid</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Identical volume of saline during emergency medical transport&#xD;
Saline control: Saline Control</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="447"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="447"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Arterial Thromboembolic event NOS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="447"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>MI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="447"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Venous Thromboembolic Event NOS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Pnuemonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="447"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="456"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="447"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="456"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jason Sperry MD, MPH</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>4128028270</phone>
      <email>sperryjl@upmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

